Z51.12 — Encounter for antineoplastic immunotherapy
Z51.12 is a billable, specific ICD-10-CM code for encounter for antineoplastic immunotherapy. It is valid for submission on a claim.
Risk adjustment
Z51.12 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
Z51.12 is named in 8 Medicare coverage policies — 8 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)
- A56494Billing and Coding: Cardiovascular Nuclear Medicine
- A56580Billing and Coding: Computerized Axial Tomography (CT), Thorax
- A56743Billing and Coding: Cardiovascular Nuclear Medicine
How Z51.12 is indexed
Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to Z51.12.
- Encounter›immunotherapy for neoplasm
- Immunotherapy›antineoplastic
Related codes at this level
Codes that share Z51.1. If Z51.12 is not quite right, the correct code is usually one of these.
Questions about Z51.12
- Is Z51.12 a billable ICD-10-CM code?
- Yes. Z51.12 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does Z51.12 sit in the tabular list?
- Factors influencing health status and contact with health services (Z00-Z99), in the block Encounters for other specific health care (Z40-Z53).